HongKong Curegene Innovation Co., Limited
1 clinical trials · Sponsor
◉ Watch HongKong Curegene Innovation Co., Limited
| Record | Firm | Date |
|---|---|---|
| A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and Multiple Doses of CG-0416 in Healthy Participants. (NCT07724431) | HongKong Curegene Innovation Co., Limited | 2026-07-01 |
Track HongKong Curegene Innovation Co., Limited automatically
Every clearance here is in the API, with alerts when new ones post.